News | December 21, 2023
AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
Development services for gene and cell therapies is planned to begin first in 2025
Development services for gene and cell therapies is planned to begin first in 2025
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
GMM Pfaudler US completes acquisition of MixPro
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Lack of technology transfer stands out as a formidable barrier
Subscribe To Our Newsletter & Stay Updated
